secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECTIS HEALTH, INC. (GBCS)
CIK:        0000727346
Form:       8-K
Filed at:   2025-01-23T23:59:59+00:00
Accession:  0001493152-25-003346
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO James Creamer resigns; CEO Adam Desmond named interim CFO
-------------------------------------------------------------

- James Creamer resigned as CFO effective January 17, 2025, under a separation agreement.
- CEO Adam Desmond will serve as Interim CFO until a permanent CFO is appointed.
- Separation Agreement and Release filed as Exhibit 10.1 to the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/727346/000149315225003346/0001493152-25-003346-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/727346/000149315225003346/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003346

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer